Singapore’s HSA approves expanded indication for Emergent BioSolutions’ ACAM2000 to include prevention of mpox disease: Gaithersburg, Maryland Monday, May 4, 2026, 13:00 Hrs [ ...
Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.
Emergent BioSolutions has been given FDA approval to extend the indications for its smallpox vaccine ACAM2000 to include the prevention of mpox, currently deemed a public health emergency by the WHO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results